Home › NDC Lookup › RxCUI directory › RxCUI 2588062

Rivaroxaban 1 MG/ML Oral Suspension — RxCUI 2588062

RxNorm drug concept · Semantic clinical drug
RxCUI 2588062 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2588062
Official nameRivaroxaban 1 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped22
Reported Medicaid activity (SDUD)651,883 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rivaroxaban: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, rivaroxaban is a blood thinner, but it covers a pretty wide range of conditions. It's used to treat blood clots in the legs (DVT) and lungs (pulmonary embolism), prevent those...
  • What exactly is rivaroxaban used for — is it just a blood thinner?
  • It depends on the strength you've been prescribed. Certain higher-strength tablets need to be taken with food — food helps your body absorb enough of the medication. Lower-strength...
  • Do I need to take rivaroxaban with food?
📖 Read our full Rivaroxaban guide →

🕸️ Concept Web — How Rivaroxaban 1 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rivaroxaban 1 MG/ML Oral Suspension RxCUI 2588062

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rivaroxaban 1114195
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xarelto 1114199
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rivaroxaban Oral Suspension 2589626
    • Rivaroxaban Oral Liquid Product 2589625
    • Rivaroxaban Oral Product 1157968
    • Rivaroxaban Oral Suspension [Xarelto] 2589630
    • Xarelto Oral Liquid Product 2589629
    • Xarelto Oral Product 1186304
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rivaroxaban 1 MG/ML SCDC · 2589624
  • Rivaroxaban Oral Suspension SCDF · 2589626
  • Rivaroxaban Oral Liquid Product SCDG · 2589625
  • Rivaroxaban Oral Product SCDG · 1157968

Brand-Name Concepts

  • Rivaroxaban 1 MG/ML Oral Suspension [Xarelto] SBD · 2588066
  • Rivaroxaban 1 MG/ML [Xarelto] SBDC · 2589628
  • Rivaroxaban Oral Suspension [Xarelto] SBDF · 2589630
  • Xarelto Oral Liquid Product SBDG · 2589629
  • Xarelto Oral Product SBDG · 1186304
  • Xarelto BN · 1114199

📦 FDA Products & Package NDCs

8 products · 22 package NDCs
22 package NDCs map to RxCUI 2588062 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50458-0575-01 1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPEN... Xarelto Janssen Pharmaceuticals, Inc. 2021-12-01
50458-0577-10 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-577-10) / 10 TAB... XARELTO Janssen Pharmaceuticals, Inc. 2018-10-09
50458-0577-14 14 TABLET, FILM COATED in 1 BOTTLE (50458-577-14) XARELTO Janssen Pharmaceuticals, Inc. 2018-10-09
50458-0577-18 180 TABLET, FILM COATED in 1 BOTTLE (50458-577-18) XARELTO Janssen Pharmaceuticals, Inc. 2018-10-09
50458-0577-60 60 TABLET, FILM COATED in 1 BOTTLE (50458-577-60) XARELTO Janssen Pharmaceuticals, Inc. 2018-10-09
50458-0578-07 7 TABLET, FILM COATED in 1 BOTTLE (50458-578-07) Xarelto Janssen Pharmaceuticals, Inc. 2016-09-20
50458-0578-10 10 BLISTER PACK in 1 CARTON (50458-578-10) / 10 TABLET, FIL... Xarelto Janssen Pharmaceuticals, Inc. 2011-11-04
50458-0578-30 30 TABLET, FILM COATED in 1 BOTTLE (50458-578-30) Xarelto Janssen Pharmaceuticals, Inc. 2011-11-04
50458-0578-90 90 TABLET, FILM COATED in 1 BOTTLE (50458-578-90) Xarelto Janssen Pharmaceuticals, Inc. 2011-11-04
50458-0579-07 7 TABLET, FILM COATED in 1 BOTTLE (50458-579-07) Xarelto Janssen Pharmaceuticals, Inc. 2016-09-20
50458-0579-10 10 BLISTER PACK in 1 CARTON (50458-579-10) / 10 TABLET, FIL... Xarelto Janssen Pharmaceuticals, Inc. 2011-11-05
50458-0579-30 30 TABLET, FILM COATED in 1 BOTTLE (50458-579-30) Xarelto Janssen Pharmaceuticals, Inc. 2011-11-05
50458-0579-89 1000 TABLET, FILM COATED in 1 BOTTLE (50458-579-89) Xarelto Janssen Pharmaceuticals, Inc. 2019-01-06
50458-0579-90 90 TABLET, FILM COATED in 1 BOTTLE (50458-579-90) Xarelto Janssen Pharmaceuticals, Inc. 2011-11-05
50458-0580-07 7 TABLET, FILM COATED in 1 BOTTLE (50458-580-07) Xarelto Janssen Pharmaceuticals, Inc. 2017-11-01
50458-0580-10 10 BLISTER PACK in 1 CARTON (50458-580-10) / 10 TABLET, FIL... Xarelto Janssen Pharmaceuticals, Inc. 2011-07-01
50458-0580-30 30 TABLET, FILM COATED in 1 BOTTLE (50458-580-30) Xarelto Janssen Pharmaceuticals, Inc. 2011-07-01
50458-0580-90 90 TABLET, FILM COATED in 1 BOTTLE (50458-580-90) Xarelto Janssen Pharmaceuticals, Inc. 2017-11-01
50458-0584-51 1 KIT in 1 CARTON (50458-584-51) * 42 TABLET, FILM COATED... XARELTO Janssen Pharmaceuticals, Inc. 2014-09-16
50458-0584-52 1 KIT in 1 CARTON (50458-584-52) * 42 TABLET, FILM COATED... XARELTO Janssen Pharmaceuticals, Inc. 2016-11-01
67877-0882-71 1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPEN... Rivaroxaban Ascend Laboratories, LLC 2025-07-07
70748-0355-01 1 BOTTLE in 1 CARTON (70748-355-01) / 1 FOR SUSPENSION in 1... rivaroxaban granule Lupin Pharmaceuticals, Inc. 2025-09-29
Observed labelers: Janssen Pharmaceuticals, Inc. (20) · Ascend Laboratories, LLC (1) · Lupin Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.